The Glucagon Test in the Diagnosis of Growth Hormone Deficiency in Children With Short Stature Younger than 6 Years
Open Access
- 1 November 2009
- journal article
- other
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 94 (11), 4251-4257
- https://doi.org/10.1210/jc.2009-0779
Abstract
Context: Few studies have addressed the diagnostic role of the glucagon test in children with suspected GH deficiency (GHD). Objective: The objective of the study was to investigate the diagnostic value of the glucagon test as an alternative test to insulin tolerance test (ITT) and arginine in GHD children younger than 6 yr. Design and Setting: This study was conducted in two pediatric endocrinology centers. Patients and Methods: Forty-eight children (median age 4.2 yr, median height −3.0 sd score) with GHD confirmed by a peak GH to ITT and arginine less than 10 μg/liter (median 4.7 and 3.4 μg/liter, respectively) underwent a glucagon stimulation test. Magnetic resonance imaging showed normal hypothalamic-pituitary anatomy in 24 children, isolated anterior pituitary hypoplasia in seven, and structural hypothalamic-pituitary abnormalities in 17. Results: Median GH peak response to glucagon (13.5 μg/liter) was significantly higher than that observed after ITT and arginine (P < 0.0001). GH peak after glucagon was less than 10 μg/liter in 20 subjects (group 1) and greater than 10 μg/liter in 28 subjects (group 2) without significant clinical or biochemical differences between the two groups. Median GH peak after glucagon was similar between patients with multiple pituitary hormone deficiency and those with isolated GHD and between subjects with and without structural hypothalamic-pituitary abnormalities. The magnitude of the GH peak after glucagon was negatively correlated to age at diagnosis (ρ = −0.636, P < 0.0001). Conclusions: This study shows that glucagon has an effective GH-releasing activity and can be used to evaluate somatotroph function in young children with short stature. Normative data for this test in young children need to be established before its use in clinical practice. Glucagon has a strong GH-releasing activity in young children with short stature. Normative data need to be established before use in clinical practice.Keywords
This publication has 22 references indexed in Scilit:
- Glucagon Stimulation Test for Childhood Growth Hormone Deficiency: Timing of the Peak is ImportantThe Journal of Pediatrics, 2009
- Relationship between GH response and glycemic fluctuations in the glucagon stimulation testGrowth Hormone & IGF Research, 2009
- Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of AustraliaActa Endocrinologica, 2007
- GH and Cortisol Response to Glucagon Administration in Short ChildrenHormone Research in Paediatrics, 2004
- Normal growth hormone secretion in growth hormone insufficient children retested after completion of linear growthClinical Endocrinology, 1996
- The assessment of growth hormone status in normal young adult males using a variety of provocative agentsClinical Endocrinology, 1996
- Intramuscular glucagon as a provocative stimulus for the assessment of pituitary function: Growth hormone and cortisol responsesMetabolism, 1987
- Betaxolol and propranolol in glucagon stimulation of growth hormone.Archives of Disease in Childhood, 1984
- The glucagon infusion test and growth hormone secretionThe Journal of Pediatrics, 1975
- The glucagon stimulation test: Effect on plasmagrowth hormone and on immunoreactive insulin, cortisol, and glucose in childrenThe Journal of Pediatrics, 1974